The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A first-in-human study of MT-303, an innovative in vivo mRNA chimeric antigen receptor (CAR) therapy targeting GPC3, in adults with hepatocellular carcinoma.
 
Timothy Humphries
No Relationships to Disclose
 
Stuart Roberts
Consulting or Advisory Role - Advisory Board Member and Counsultant at Astra Zeneca; Advisory board member and speaker at Rouche
 
Hao-Wen Sim
Honoraria - Lilly; Servier Australia
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst)
 
Yoon Jun Kim
Research Funding - AstraZeneca (Inst); Celltrion (Inst); Dong-A Pharm (Inst); Yuhan
 
Hong Jae Chon
Consulting or Advisory Role - Aptamer Sciences Inc; AstraZeneca; Bayer; BeiGene; BMS; Eisai; MSD; Ono Pharmaceutical; Roche; Sanofi; SERVIER
Speakers' Bureau - AstraZeneca; Bayer; BMS; Dong-A ST; Eisai; Roche; Sanofi; SERVIER
Research Funding - BeiGene (Inst); Boryung (Inst); Dong-A ST (Inst); Hanmi (Inst); inno-n (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Medivir (Inst)
 
Jeong Heo
Honoraria - Roche
Consulting or Advisory Role - AstraZeneca/MedImmune; Medvir; Surrozen
Speakers' Bureau - Abbvie; AstraZeneca/MedImmune; Gilead Sciences; Gilead Sciences; Oncolys BioPharma; Roche; Yuhan
Research Funding - Gilead Sciences; Roche
 
Heather Cohen
Employment - Bicycle Therapeutics; Myeloid Therapeutics
Stock and Other Ownership Interests - Bicycle Therapeutics
Patents, Royalties, Other Intellectual Property - Bibyle Therapeutics
 
Michele Cioffi
Employment - Myeloid Therapeutics
Travel, Accommodations, Expenses - Myeloid Therapeutics
 
Miriam Barnett
No Relationships to Disclose
 
Matthew Maurer
Employment - IDEAYA Biosciences; Myeloid Therapeutics
Leadership - Myeloid Therapeutics
Stock and Other Ownership Interests - Bristol-Myers Squibb; IDEAYA Biosciences; Myeloid Therapeutics
Consulting or Advisory Role - Jaymes Holland
 
Vladimir Andelkovic
Stock and Other Ownership Interests - Moleculin Biotech
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Eisai
Research Funding - Ayala Pharmaceuticals (Inst); BMS (Inst); Boehringer Ingelheim (Inst); MSD (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Novartis